The estrogen receptor-negative and HER2+SKBR3 cell line is representative of a recently identified breast cancer subtype characterized by co-amplification of the genes coding for the HER2 membrane receptor (ERBB2) and the RARα nuclear retinoid receptor (RARA), respectively [1]. The gene discussed is ERBB2; the disease is breast carcinoma.